This review elucidates the basic science mechanisms of transmembrane signaling induced by endothelin, a potent vasoconstrictor peptide.
Answers are grounded in this paper and cite their sources.
No immediate change to hypertension care; leaves open whether these endothelin-Ca2+ and phospholipase pathways warrant targeted trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Simonson et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: